Ignite Creation Date:
2025-12-26 @ 11:14 AM
Ignite Modification Date:
2025-12-31 @ 11:36 AM
Study NCT ID:
NCT03188328
Status:
TERMINATED
Last Update Posted:
2019-07-05
First Post:
2017-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, PK, Dosimetry, MTD and Preliminary Efficacy of Intra-lesionally Injected AvidinOX, Followed by IV Escalating Doses of [177Lu]DOTA-biotin in Pts With Injectable Solid Tumors or Lymphomas
Sponsor:
Alfasigma S.p.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-13
First Submit QC Date:
None
Study First Post Date:
2017-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-01
Last Update Post Date:
2019-07-05
Last Update Post Date Type:
ACTUAL